Treatment and follow-up of coronary artery disease in a child with homozygous familial hypercholesterolemia
Familial hypercholesterolemia is a metabolic disease caused by a mutation in the low-density lipoprotein receptor gene. It carries early atherosclerosis and coronary artery disease risks. Coronary artery disease has been reported 20 times in the pediatric population with familial hypercholesterolemi...
Main Authors: | Mehmet Oncul, Cemsit Karakurt, Ozlem Elkiran, Aysehan Akinci, Nevzat Erdil |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Turaz Bilim
2022-03-01
|
Series: | Medicine Science |
Subjects: | |
Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=103899 |
Similar Items
-
Unraveling the proteomic signatures of coronary artery disease and hypercholesterolemia
by: Gulsen Guliz Anlar, et al.
Published: (2024-10-01) -
Possible mechanisms of hypercholesterolemia and clinico-prognostic effects of lipid-lowering therapy in patients with coronary heart disease. (Literature review and original data analysis)
by: A. P. Vasilyev, et al.
Published: (2004-12-01) -
Homozygous familial hypercholesterolemia: modern aspects of pathogenesis, diagnostics and treatment
by: V. К. Zafiraki, et al.
Published: (2018-10-01) -
2024 Polish recommendations for the management of familial hypercholesterolemia in children and adolescents
by: Małgorzata Myśliwiec, et al.
Published: (2024-11-01) -
Premature Coronary Artery Disease due to Homozygous Familial Hypercholesterolemia in a 12-Year-Old Girl
by: Filiz Ekici, et al.
Published: (2018-03-01)